Skip to main content
Premium Trial:

Request an Annual Quote

Inflammatix: Amy Boyle

Inflammatix has appointed Amy Boyle as its chief operating officer. Boyle has 30 years of commercial medical device experience, with expertise in strategy, market development, sales and marketing, commercial operations, and manufacturing.

Most recently, she served as vice president, strategy, planning, and marketing for the health solutions division of Flex. Prior to that, she was vice president, marketing for the urology division of Coloplast, where she led global expansion and growth of the surgical urology business, and launched the firm's endourology portfolio in the US.

Previously, Boyle was executive vice president of marketing for Imris and spent five years at St. Jude Medical, first as vice president, marketing, international, responsible for cardiovascular businesses, and then as vice president, corporate brand and marketing. She also spent 17 years with Medtronic in Canada and the US in a variety of sales roles, including regional vice president of sales for the cardiac rhythm management business.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.